Ultrafast pump−probe studies of room-temperature solutions of 3-hydroxyflavone (3-HF) and some
4‘-substituted derivatives have been undertaken. Transient absorption attributable to the two zwitterionic forms
of the excited tautomer arising from excited-state intramolecular proton transfer (ESIPT) was observed across
most of the visible spectral region. For 3-HF in methylcyclohexane and acetonitrile, the ESIPT was found to
be so rapid that it was only possible to assign a time constant of 35 fs to the process. In ethanol, however,
a time constant of 60 fs was determined. The slower ESIPT in this solvent was attributed to the greater
strength of the solute−solvent interactions. For the derivatives of 3-HF in all three solvents, the ESIPT step
was also found to be instrument-limited. In addition to the femtosecond kinetics, there was also a picosecond
component of the kinetics that is attributed to ESPT in molecules that are intermolecularly hydrogen bonded
to the solvent.
Donor–acceptor
Stenhouse adducts (DASAs) are negative photochromes
that hold great promise for a variety of applications. Key to optimizing
their switching properties is a detailed understanding of the photoswitching
mechanism, which, as yet, is absent. Here we characterize the actinic
step of DASA-photoswitching and its key intermediate, which was studied
using a combination of ultrafast visible and IR pump–probe
spectroscopies and TD-DFT calculations. Comparison of the time-resolved
IR spectra with DFT computations allowed to unambiguously identify
the structure of the intermediate, confirming that light absorption
induces a sequential reaction path in which a Z–E photoisomerization of C2–C3 is followed
by a rotation around C3–C4 and a subsequent
thermal cyclization step. First and second-generation DASAs share
a common photoisomerization mechanism in chlorinated solvents with
notable differences in kinetics and lifetimes of the excited states.
The photogenerated intermediate of the second-generation DASA was
photo-accumulated at low temperature and probed with time-resolved
spectroscopy, demonstrating the photoreversibility of the isomerization
process. Taken together, these results provide a detailed picture
of the DASA isomerization pathway on a molecular level.
The triplet excited state properties of two BODIPY phenothiazine dyads (BDP-1 and BDP-2) with different lengths of linker and orientations of the components were studied. The triplet state formation of BODIPY chromophore was achieved via photoinduced electron transfer (PET) and charge recombination (CR). BDP-1 has a longer linker between the phenothiazine and the BODIPY chromophore than BDP-2. Moreover, the two chromophores in BDP-2 assume a more orthogonal geometry both at the ground and in the first excited state (87°) than that of BDP-1 (34-40°). The fluorescence of the BODIPY moiety was significantly quenched in the dyads. The charge separation (CS) and CR dynamics of the dyads were studied with femtosecond transient absorption spectroscopy (k = 2.2 × 10 s and 2 × 10 s for BDP-1 and BDP-2, respectively; k = 4.5 × 10 and 1.5 × 10 s for BDP-1 and BDP-2, respectively; in acetonitrile). Formation of the triplet excited state of the BODIPY moiety was observed for both dyads upon photoexcitation, and the triplet state quantum yield depends on both the linker length and the orientation of the chromophores. Triplet state quantum yields are 13.4 and 97.5% and lifetimes are 13 and 116 μs for BDP-1 and BDP-2, respectively. The spin-orbit charge transfer (SO-CT) mechanism is proposed to be responsible for the efficient triplet state formation. The dyads were used for triplet-triplet annihilation (TTA) upconversion, showing an upconversion quantum yield up to 3.2%.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.